Examples of using Nitisinone in English and their translations into Polish
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Ecclesiastic
-
Financial
-
Official/political
-
Programming
-
Computer
Adjunct to the nitisinone treatment, a diet deficient in phenylalanine and tyrosine is required
Each capsule contains 2 mg nitisinone Each capsule contains 5 mg nitisinone Each capsule contains 10 mg nitisinone Each capsule contains 20 mg nitisinone.
Nitisinone has shown embryo-foetal toxicity in the mouse and rabbit at clinically relevant dose levels.
lymphatic system disorders' subsided during continued nitisinone treatment.
By inhibiting the normal catabolism of tyrosine in patients with HT-1, nitisinone prevents the accumulation of the toxic intermediates maleylacetoacetate and fumarylacetoacetate.
The safety profile is mainly based on the paediatric population since nitisinone treatment should be started as soon as the diagnosis of hereditary tyrosinemia type 1(HT-1) has been established.
Orfadin 2 mg hard capsules Orfadin 5 mg hard capsules Orfadin 10 mg hard capsules Orfadin 20 mg hard capsules nitisinone.
Therefore, it is recommended that if nitisinone treatment is initiated with food,
Orfadin 2 mg hard capsules Orfadin 5 mg hard capsules Orfadin 10 mg hard capsules nitisinone.
In the rabbit, nitisinone induced a dose-related increase in malformations(umbilical hernia and gastroschisis)
Nitisinone treatment leads to normalised porphyrin metabolism with normal erythrocyte porphobilinogen synthase activity
In 10 healthy male volunteers, after administration of a single dose of nitisinone capsules(1 mg/kg body weight) the terminal half-life(median) of nitisinone in plasma was 54 hours ranging from 39 to 86 hours.
Nitisinone treatment leads to normalised porphyrin metabolism with normal erythrocyte PBG- synthase activity and urine 5-ALA, decreased urinary excretion of succinylacetone,
If urine succinylacetone is still detectable one month after the start of nitisinone treatment, the nitisinone dose should be increased to 1.5 mg/kg body weight/day divided in 2 doses.
it can be seen that treatment with nitisinone together with dietary restriction results in a better survival probability in all HT-1 phenotypes.
By its mode of action, nitisinone increases tyrosine levels in all nitisinone treated patients.
The active substance in Orfadin, nitisinone, blocks an enzyme that converts tyrosine into harmful substances.
Nitisinone treatment leads to elevated tyrosine levels.
Lactation It is not known whether nitisinone is excreted in human breast milk.
Nitisinone treatment is associated with elevated tyrosine levels.